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Abstract.  Sphingosylphosphorylcholine  (SPC), or lyso- 
phingomyelin,  a  wide-spectrum  growth promoting 
agent for a  variety of cell types (Desai,  N.  N.,  and  S. 
Spiegel.  1991.  Biochem.  Biophys.  Res.  Comm.  181: 
361-366),  stimulates  cellular proliferation  of quiescent 
Swiss 3T3 fibroblasts to a greater extent than  other 
known growth factors or than the structurally  related 
molecules,  sphingosine  and sphingosine-l-phosphate. 
SPC potentiated  the mitogenic effect of an activator of 
protein kinase C,  12-O-tetradecanoylphorbol  13-acetate, 
and did not compete with phorbol esters for binding 
to protein  kinase  C  in intact  Swiss 3T3 fibroblasts. 
However, downregulation  of protein kinase  C,  by pro- 
longed treatment  with phorbol  ester,  reduced,  but did 
not eliminate,  the ability of SPC to stimulate  DNA 
synthesis,  indicating  that  SPC may act via both protein 
kinase  C-dependent  and -independent  signaling  path- 
ways. SPC induced a  rapid  rise in intracellular  free 
calcium ([Ca2+]i) in viable 3T3 fibroblasts determined 
with a digital  imaging  system.  Although the increases 
in [Ca2+]i were observed even in the absence of calcium 
in the external  medium,  no increase  in the levels of 
inositol phosphates  could be detected in response to 
mitogenic concentrations  of SPC.  Furthermore,  in con- 
trast to sphingosine  or sphingosine-l-phosphate,  the 
mitogenic effect of SPC was not accompanied by in- 
creases in phosphatidic acid levels or changes in cAMP 
levels. SPC, but not sphingosine or sphingosine-l-phos- 
phate, stimulates the release of arachidonic acid. There- 
fore, the ability of SPC to act as an extremely potent 
mitogen may be due to activation  of signaling  path- 
way(s) distinct  from those used by sphingosine  or 
sphingosine-l-phosphate. 
PHINGOSINE and lysophingolipids have been implicated 
in  signal  transduction  in  various  cellular  processes 
(Hannun  and Bell,  1987,  1989;  Merrill  and Stevens, 
1989; Merrill,  1991). It is well established that sphingosine 
and other lysosphingolipids have diverse biological functions 
that are dependent on protein  kinase  C  (PKC),~  a  pivotal 
regulatory enzyme in signal transduction (Harmun and Bell, 
1987,  1989; Merrill and Stevens, 1989). Nevertheless, other 
studies indicate a more versatile role for sphingosine which 
does not seem to be restricted to its effects on PKC (Davis 
et al.,  1988; Faucher et al.,  1988; Zhang et al.,  1990a; and 
for review see Merrill,  1991).  We have previously reported 
that sphingosine possesses growth-promoting effects in 3T3 
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1. Abbreviations used in this paper: AA, arachidonic acid; [Ca2+]i, intra- 
cellular free calcium; BK, peptide hormone bradykinin; InsP3, inositol 
trisphosphate; PA, phosphatidic acid; PDBu, phorbol 12, 13-dibutyrate; 
PKC, protein ldnase C; SPC, sphingosylphosphorylcholine;  SPP, sphingo- 
sine-l-phosphate; TG, thapsigargin; TPA, 12-O-tetradecanoylphorbol-13- 
acetate. 
fibroblasts that are clearly independent ofPKC (Zhang et al., 
1990a). The mitogenic action of sphingosine is coupled to 
an increase in the levels of phosphatidic acid (PA) (Zhang et 
al., 1990b) and mobilization of calcium from internal stores 
(Zhang et al.,  1991). 
Metabolites of sphingosine  have been shown to be pro- 
duced  in  cells  and  to  have potent  effects on  cell  growth 
(Hakomori,  1990;  Zhang  et  al.,  1991).  Hakomori  et  al. 
found  that  a  methylated  derivative  of sphingosine,  N,N- 
dimethylsphingosine, was much more effective than sphingo- 
sine in inhibition of PKC and stimulation of src-kinase and 
EGF receptor tyrosine kinase activity (Igarashi et al.,  1990; 
Felding-Habermann et al., 1990; Hakomori, 1990). In addi- 
tion, experiments performed in our laboratory have shown 
that a different sphingosine-derived metabolite, sphingosine- 
1-phosphate (SPP), which mimics the effects of sphingosine 
on PA and calcium release, is also a very potent mitogen for 
3T3 fibroblasts (Zhang et al.,  1991;  Desai et al.,  1992). 
Recently, we reported that another sphingoid base, sphin- 
gosylphosphorylcholine  (SPC) or lysosphingomyelin,  is  a 
powerful mitogen that stimulates DNA synthesis and cellular 
proliferation of Swiss 3T3 fibroblasts and a variety of other 
cell types (Desai and Spiegel,  1992). In the present study, 
we attempted to elucidate the signal transduction pathways 
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synthesis is considered to be triggered by several indepen- 
dent signal transduction pathways that act  synergistically 
(Rozengurt, 1986).  The most well known pathways are as- 
sociated with intracellular messengers such as cAMP,  di- 
acylglycerol, an endogenous activator of PKC (Nishizuka, 
1992),  and inositol trisphosphate (InsP3),  which causes a 
release of Ca  2÷ from intracellular stores (Berridge and Ir- 
vine, 1989).  Other less well-defined second messengers in- 
clude PA (Exton, 1990) and arachidonic acid (AA) (Irvine, 
1982;  Burch  and Axelrod,  1987) generated by receptor- 
coupled  activation  of phospholipases  D  and  A2,  respec- 
tively. We report here that of these potentially important sig- 
naling pathways for mitogenesis, SPC induced changes only 
in intracellular calcium levels and AA metabolism in Swiss 
3T3 fibroblasts, suggesting that the ability of SPC to act as 
a potent mitogen may be due to activation of unique signaling 
pathways distinct from those used by sphingosine or SPP. 
Materials and Methods 
Materials 
[methyl3H]Thymidine (55 Ci/mmol) and myo-[2-3H]inositol (15 Ci/mmol) 
and  [N-methyl-14C]sphingomyelin (50-60  mCi/mmol)  were  purchased 
from Amersham Corp. (Arlington Heights, IL). EGF, insulin, and transfer- 
rin  were  from  Collaborative  Research  (Lexington,  MA).  12-O-Tetra- 
decanoylphorbol-13-acetate (TPA),  o-sphingosine, and  SPC  were  from 
Sigma Chem. Co.  (St. Louis, MO). Thapsigargin was from Calbiochem 
(San Diego, CA). The various standard phospholipids were from Avanti Po- 
lar Lipids (Birmingham, AL). Silica Gel 60 plates were from EM Sciences 
(Cherry Hill, NJ). DMEM and PBS were from Advanced Biotechnologies 
(Silver  Spring,  MD),  and  Waymouth  medium  was  from GIBCO  BRL 
(Gaithersburg, MD). Fura-2/AM was from Molecular Probes Inc. (Eugene, 
OR). SPP was prepared as previously described (Zhang et al.,  1991). 
Cell Culture 
Swiss 3T3  cells from the American Type Culture Collection, Rockville, 
MD (CCL 92) were cultured as previously described (Spiegel, 1989).  For 
measurement of DNA synthesis, cAMP accumulation, and AA release, the 
cells were seeded and grown on multicluster plastic tissue culture dishes (24 
x  16 nun wells, from Costar Corp., Cambridge, MA). For phospholipid 
analysis and phosphoinositide  assays, the cells were cultured in 6-well clus- 
ter tissue culture dishes (6 x  34 mm wells, from Costar Corp.) For mea- 
surements of intracellular free Ca  2+  ([Ca2]i),  cells were grown on glass 
coverslips in 6-well clusters. The cells were subcultured at a density of 1.5 
×  104 cells/cm  2 in DMEM supplemented with 2 mM glutamine, penicillin 
(100 U/ml), streptomycin (100 ttg/ml), and 10% calf serum, refed with the 
same medium after 2 d, and used 5 d later when the cells were confluent 
and quiescent (Spiegel and Panagiotopoulos, 1988). 
Assay of  DNA Synthesis 
DNA synthesis was measured as previously described (Spiegel and Panag- 
iotopoulos,  1988).  After  18  h  of incubation with test agents,  1 #Ci of 
[3H]thymidine was added, the cells were incubated an additional 6 h, and 
the incorporation of radioactivity into TCA-insoluble material was mea- 
sured (Spiegel and Panagiotopoulos, 1988).  Values are the means of tripli- 
cate determinations. Standard errors were routinely <10%  of the mean. 
Uptake and Metabolism of  Radiolabeled SPC 
[N-methyl-t'*C]sphingomyelin was  converted  to  [N-methyl-14C]SPC  by 
treatment with 0.5 M HCI in methanol (1 /zCi/ml)  at 65°C for 3 h and ex- 
tracted  with  chloroform/methanol/water (8:4:3,  vol/vol).  The  aqueous 
phase was removed, the pH was adjusted to 12, and the lipids reextracted 
with an equal volume of chloroform. The radioactivity present in the or- 
ganic phase was solely SPC as determined by TLC. After evaporation of 
the chloroform, the labeled SPC was solubilized in DMEM containing 10 
/~M unlabeled SPC to a final specific activity of 1 mCi/mmol. Two ml of 
this solution were added to confluent and quiescent 3"I"3 cells in 6-well 
clusters and incubated at 37°C for various times. The medium was removed 
and the cells were washed three times with 2  ml of ice cold DMEM. 
Medium and cells were extracted with chloroform/methanol/water (8:4:3, 
vol/vol) and the pH of the aqueous phase was increased to 12 with 10 M 
KOH to optimize recovery of SPC in the organic phase. The extracted lip- 
ids were analyzed by TLC  (solvent system: chloroform/methanol/water 
(70:35:8,  vol/vol). 
Mass Measurement of Ceramide and Sphingosine 
The mass amounts of ceramide in cellular extracts were measured by the 
use of the DAG kinase enzymatic method (Schneider and Kennedy, 1973; 
Dressier and Kolesnick, 1991). Cells were treated with SPC or vehicle for 
various incubation periods. To quantitate ceramide levels, lipids were ex- 
tracted, and then subjected to the action ofE. coli DAG kinase as described 
previously (Olivera et al.,  1992),  and ceramide-l-phosphate was resolved 
by TLC with chloroform/methanol/acetic acid (65:15:5,  vol/vol). Known 
amounts of ceramide standards were included with each assay. Sphingosine 
levels were measured by a similar enzymatic assay using sphingosine  kinase 
partially purified from Swiss 3T3 fibroblasts (Olivera et al.,  1992). 
Measurement of  Specific Binding of  Phorbol Ester 
Binding of [3H]PDBu to cells in situ was measured essentially as described 
(Spiegel, 1989).  Briefly, confluent and quiescent cultures were washed and 
incubated with DMEM containing 25 mM Hepes, pH 7.4,  and 0.1% fatty 
acid free-BSA. Cells were treated with various concentrations of [3H]- 
PDBu (1-100 nM) in the absence or presence of SPC. After 2 h at 0°C, the 
ceils were washed with 2  x  1 ml of ice cold PBS-0.1% fatty acid free-BSA, 
dissolved in 0.2 N NaOH, and assayed for bound ligand. Nonspecific bind- 
ing, measured by the addition of 1/zM unlabeled TPA, was subtracted from 
the total binding. 
Measurements of  lntraceUular Free 
Ca  2÷ Concentration 
[Ca2+]i was determined with the fluorescent calcium-sensitive dye fura- 
2/AM as described previously (De Erausquin et al.,  1990;  Zhang et al., 
1991). Briefly, cells grown on glass coverslips were loaded with 10/zM fura- 
2/AM for 60 min in DMEM at 370C, washed three times with Locke's buffer 
(154 mM NaCI, 5.6 mM KC1, 3.6 mM NaHCO3, 2.3 mM CaCI2, 5.6 mM 
glucose, 5 mM Hepes, pH 7.4),  and mounted in a 35-mm holder. Changes 
in fura-2 fluorescence in single cells were monitored by dual excitation im- 
aging using a Digital Fluorescence Microscopy System (Atto Instrs. Inc., 
Rockville, MD). [Ca2+]i was determined from the ratio of fura-2 fluores- 
cence emissions after excitation at the dual wavelength pair of 334 and 380 
nm (De Erausquin et al.,  1990).  For experiments done at 37"C, the mito- 
gens were dissolved in Locke's solution and perfused over the cells at 1 ml/ 
min with a peristaltic pump. In the experiments where the ceils were chal- 
lenged repeatedly with SPC,  each treatment was  followed by a  10-min 
period before the next challenge, to allow the intracellular calcium concen- 
trations to return to basal levels. 
Measurement of  Phosphoinositide Breakdown 
Confluent cultures of Swiss 3T3 cells were prelabeled for the final 60 h of 
growth with myo-[2-aH]inositol (5/zCi/ml). Cells were rinsed twice with 
DMEM containing 10 mM LiCI, incubated for 5 min at 37°C to remove 
free inositol, and then treated with various mitogenic compounds or vehi- 
cle. At the end of  the incubation period, the medium was removed by aspira- 
tion and the reactions terminated by the addition of chloroforrn/metha- 
nol/4N  HCI  (100:200:2  vol/vol).  After extraction,  the aqueous  phases 
containing the inositol phosphates were separated on Dowex AG-1 x  8 ion- 
exchange columns as previously described (Spiegel and Panagiotopoulos, 
1988). 
Phosphatidic Acid Determination 
Confluent and quiescent cultures of 3T3 cells were washed with phosphate- 
free DMEM and incubated with this medium containing 32p  i (40 ~Ci/ml) 
for 24 h. Cells were treated with sphingosine, SPC, or vehicle alone for vari- 
ous times, the medium was rapidly removed, and lipids were extracted 
(Zhang et al.,  1990b).  PA was analyzed by TLC using the organic phase 
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vol/vol) (Pai et al.,  1988;  Zhang etal., 1990b). In this system, PA (Rf = 
0.1) was well separated from other phospholipids (Rf =  0). The lipid stan- 
dards were visualized by spraying with molybdenum blue spray. Phospho- 
lipids were located by autoradiography and the radioactivity was quantified 
by liquid scintillation counting of the corresponding silica gel areas. 
Assay for Cyclic AMP 
Cells were incubated for 20 min at 37°C in DMEM containing 0.1  mM 
l-methyl-3-isobutylxanthine,  a phosphodiesterase inhibitor, with or without 
10 ttM isoproterenol. 10 ttM SPC or vehicle was then added, and 20 min 
later, the medium was aspirated and cAMP extracted from the cells with 
1 ml 0.1 M HC1 containing 0.1 mM CaCI2 and measured by radioinununo- 
assay as described previously (Zhang et al.,  1990b). 
Assay for Arachidonic Acid Release 
Confluent cultures  of Swiss  3T3  cells  were  prelabeled  for  24  h  with 
[3H]AA (0.25/xCi/ml), which resulted in 60-90% incorporation of the la- 
bel. Cells were washed twice with DMEM containing 20 mM Hepes (pH 
7.4).  After stimulation with different agents in the presence of BSA (20 
#g/ml), aliquots of the medium were taken, centrifuged at 500 g for 5 min 
to remove floating cells, and the resulting supernatants counted for radioac- 
tivity. In some experiments, the medium was acidified and extracted twice 
with an equal volume of ethyl acetate. The extracted lipids were analyzed 
by  TLC  (silica  gel  60,  petroleum ether/diethyl ether/cone,  acetic  acid 
(80:20:1  vol/vol) to separate phospholipids, eicosanoids, and free AA, as 
previously described (Carlson and Levitan,  1990).  In other experiments, 
lipids extracted from cells were analyzed by two-dimensional  TLC as previ- 
ously described (Zhang et al.,  1991). 
Results 
Mitogenicity of SPC Relative to Lysophospholipids 
and Other Sphingolipids 
SPC greatly stimulated DNA synthesis and cell division of 
quiescent cultures of Swiss 3T3 fibroblasts (Desai and Spie- 
gel,  1991).  Consistent with our previous study, SPC caused 
a  dose-dependent  increase in  [3H]thymidine incorporation 
into DNA, with maximum effect at 10 #M (Fig.  1). At con- 
centrations greater than 30 ftM, SPC inhibited DNA synthe- 
sis and was cytotoxic, as determined by Trypan blue dye ex- 
clusion.  Previously, we have demonstrated that sphingosine 
and  its  phosphorylated  derivative,  SPP,  also  stimulated 
proliferation  of quiescent  3T3  fibroblasts  (Zhang  et  al., 
1990a;  Zhang etal.,  1991).  Thus it was of interest to com- 
pare the mitogenic properties of these structurally  related 
compounds. As can be seen in Table I, SPC stimulated DNA 
synthesis to a greater extent than sphingosine, SPP, and other 
known growth factors.  Moreover, in contrast to insulin or 
EGF, whose action require their continuous presence for at 
least 6 h (Dicker and Rozengurt,  1978), SPC induced DNA 
synthesis after a short treatment. Exposure of the fibroblasts 
to SPC for 10 min, 1 and 3 h, respectively, followed by wash- 
ing, resulted in 50, 72, and 78% of maximum DNA synthesis 
induced by 24 h of exposure. 
The mitogenic effect of SPC was also compared with the 
effects of similar concentrations of other lysophospholipids 
(Table II). None of the compounds tested were as potent as 
SPC.  Only  lysophosphatidylcholine and platelet-activating 
factor had  significant mitogenic activity,  albeit much less 
than SPC (Table II). The effect of sphingomyelin, which has 
a fatty acyl moiety linked at the amino group of SPC on DNA 
synthesis, was also examined. Since sphingomyelin is rela- 
tively insoluble in aqueous solutions, sphingomyelin vesicles 
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Figure I. Dose response for stimulation of DNA synthesis in Swiss 
3T3 cells by SPC. Confluent and quiescent cultures of Swiss 3T3 
cells were incubated with various concentrations of SPC in the ab- 
sence (o) or the presence of 100 nM of TPA (o) and [3H]thymi- 
dine  incorporation  was measured  as described  in Materials  and 
Methods. The data are expressed as fold stimulation relative to the 
untreated control. Similar results were obtained in at least five addi- 
tional experiments. The amount of [3H]thymidine incorporated  in 
untreated or TPA-treated cells was 3.9 -t- 0.4 and 20.4 +  1.4 (cpm 
x  10-3/well, respectively. 
were used in these studies (Pagano and Weinstein,  1978). 
Sphingomyelin (0.1-15 #M) did not stimulate [3H]thymidine 
incorporation either alone (N =  3), or in the presence of in- 
sulin (N =  7), or TPA (N =  8). 
Uptake and Metabolism of SPC 
in Swiss 3T3 Fibroblasts 
Since SPC is more potent than sphingosine, SPP, spingomye- 
lin (Table I), and ceramide (Olivera et al., 1992) in stimulat- 
ing DNA synthesis, it seems most likely that SPC itself is 
the active agent. To examine this point further, we have stud- 
Table L Effects of Sphingosylphosphorylcholine, 
Sphingosine, and Sphingosine-l-Phosphate on 
DNA Synthesis 
[3H]Thymidine incorporation  (cpm x  10-3/well) 
Sphingoid bases 
None  SPC  Sphingosine  SPP 
Mitogens 
None  6  149  11  16 
Insulin  13  332  25  40 
EGF  42  448  89  101 
Insulin plus EGF  251  656  366  429 
Quiescem cultures of Swiss 3T3 cells were exposed to the indicated mitogens 
in the absence or presence of the sphingoid bases. [3H]Thymidine incorpora- 
tion was measured as described in Materials  and Methods. Each value is the 
mean of triplicate determinations from a representative  experiment. SDs were 
routinely <10%. Similar results were obtained in at least seven additional ex- 
periments. The concentrations  used were: Insulin, 2/zg/ml; EGF, 10 ng/ml; 
SPC, 10 #M; sphingosine, 20/zM; and SPP, 5 ltM. 
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in Quiescent Swiss 3T3 Fibroblasts by Various 
Lysoglycerophospholipids 
[~H]Thymidine incorporation 
Stimulus  (% of response to SIC) 
A  SPC  100  5:4 
None  11  +  3 
Lysophosphatidic acid  13  +  3 
Lysophosphatidylcholine  40  5:3 
Lysophosphatidylethanolamine  19  5:1 
Lysophosphatidylserine  22  5:3 
Lysophosphatidylinositol  12  5- 2 
B  SPC  100  5:6 
None  6  +  1 
Platelet-activating factor  22  5:2 
Lyso-platelet-activating factor  14  5:1 
In two separate  experiments (A and B) quiescent  cultures  of Swiss 3T3 cells 
were stimulated  with SPC or the indicated lysoglyeerophospholipids  (10 #M) 
for 24 h. [3H]Thymidine incorporation  was measured as described in Materi- 
als and Methods. 
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Figure 2. Kinetics of uptake and metabolism of radiolabeled SPC. 
Confluent and quiescent 3T3 fibroblasts were incubated at 37°C 
with  10 #M [N-methylJ4C]SPC (1 mCi/mmol) for the indicated 
time periods. After extraction, lipids were separated by TLC and 
analyzed as described in Materials and Methods. In A, the extent 
of uptake of [14C]SPC is expressed as percent of total  [14C]SPC 
added. In B, the percent of the cell-associated radioactivity that co- 
migrated on TLC with authentic SPC is depicted. 
ied  the  cellular  uptake  and  metabolism  of  [N-methyl- 
14C]SPC.  t4C-Labeled SPC (10 #M;  1 mCi/mmol) was rap- 
idly taken up by Swiss 3T3 fibroblasts; 38% of the label was 
incorporated within 10 min. This was followed by a slower 
phase of incorporation and by 18 h, 76 % of the label was 
taken up by the cells. After 1 h,  ~4C-labeled SPC was the 
only  labeled  lipid  detected  by  TLC  and  there  was  no 
significant labeling of lysoPC, PC, or sphingomyelin. Over 
the next 3 h, '~30% of the SPC taken up was broken down 
or converted to other products and by 18 h 55 % of the SPC 
taken up had undergone metabolism (Fig.  2).  Choline or 
phosphocholine accounted for a  significant portion of the 
SPC metabolic products. Radiolabeled sphingomyelin, which 
was detectable by 3 h,  represented only 1.3%  of the total 
SPC taken up. This increased to 5.9% of the total uptake by 
18 h. This production of radiolabeled sphingomyelin may be 
due to a very slow acylation of [~4C]SPC or reutilization of 
its  breakdown  products.  We  also  measured  the  levels of 
sphingosine and ceramide,  which  can potentially be pro- 
duced from SPC by degradation and reacylation. There were 
no changes in sphingosine levels up to 1 h of treatment with 
SPC and the level slightly increased after 3 and 18 h to 145 
and 158 % of control values, respectively. It should be noted 
that this represents only a very small fraction of the SPC that 
was taken up.  No detectable increase in ceramide was ob- 
served. 
Role of  PKC in the Mitogenic Response Induced 
bySPC 
SPC potentiated the mitogenic effect  of TPA in quiescent cul- 
tures of Swiss 3T3 cells in a concentration-dependent man- 
ner (Fig.  1). This effect was observed even in the presence 
of insulin, which also potentiated the mitogenic response to 
TPA (Table III; Desai and Spiegel, 1991). Hannun and Bell 
found that SPC and other lysosphingolipids inhibited phor- 
bol dibutyrate (DPBu) binding as well as activity of PKC in 
micellar  assays  (Hannun  and  Bell,  1987).  To  determine 
whether SPC interacted with PKC in intact Swiss 3T3 fibro- 
blasts,  we examined the effects of SPC on PDBu binding. 
Table III. Effect of  Prolonged Phorbol Ester Pretreatment 
on Reinitiation of DNA Synthesis Induced by SPC 
[3H]Thymidine incorporation 
(cpm x  lOWwell) 
TPA 
Control  pretreated 
Stimulus 
None  2.9  +  0.2  4.7  +  0.5 
SPC  94.0  5:3.3  48.0  +  0.5 
TPA  29.9  5:6.8  6.8  +  1.9 
Insulin  6.7  +  1.0  29.5  +  6.0 
Insulin  +  SPC  208  5:55.0  114.0  5:5.2 
Insulin  +  TPA  82.0  5:4.2  16.0  5:4.8 
Control cultures or cultures pretreated for 24 h with 1 #M TPA were washed 
thoroughly, and then incubated in DMEM/Waymouth (1:1) supplemented with 
20 ~,g/ml BSA and 5 #g/ml transferrin in the presence of the indicated mito- 
gens. [3H]Thymidine incorporation  into DNA was measured as described in 
Materials  and Methods. Each value is the mean 5: SD of triplicate determina* 
tions from a representative experiment. Similar results were obtained in at least 
five additional experiments. The concentrations of the mitogens were: SPC, 10 
#M; TPA, 100 nM; and Insulin, 2 #g/ml. 
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Figure 3. Effect of SPC on specific binding of [3H]- 
PDBu to Swiss 3T3 cells. (A) Confluent and quiescent 
cultures were incubated in the absence (o) or pres- 
ence  (e) of SPC  (10 #M)  for 1 h,  and  [3H]PDBu 
binding was measured as described in Materials and 
Methods. In B, the cells were pretreated with different 
concentrations of SPC for 1 h and specific [3H]PDBu 
binding (25 nM) was measured. The data are expressed 
as percent of control (100% =  1.12 :t: 0.08 pmol/106 
cells).  Calculated  Kd values  for control  and  SPC- 
treated cells were 32.1 + 5.6 nM and 26.9 + 5.5 riM, 
respectively. 
Similar  to  results  previously reported  in  Swiss  3T3  cells 
(Dicker and Rozengurt,  1978;  Rozengurt,  1986;  Zhang et 
al.,  1990a), half-maximal [3H]PDBu binding occurred at a 
concentration of 15 nM (Fig. 3 A). Mitogenic concentrations 
of SPC (~<10/~M) had no effect on the binding of [3H]PDBu 
to  its  specific  receptors  on  intact  cells  (Fig.  3  A).  Even 
higher concentrations of SPC did not result in any significant 
displacement of PDBu (Fig. 3 B), indicating that SPC does 
not compete with PDBu binding sites on PKC. 
To further investigate the role of PKC in the mitogenic re- 
sponse induced by SPC, we studied the effects of the selective 
removal of this enzyme by prolonged treatment of cells with 
phorbol ester.  Prolonged exposure of quiescent cultures of 
Swiss 3T3 cells to TPA leads to downregulation of PKC enzy- 
matic activity (Rozengurt,  1986;  Spiegel,  1989)  and [3H]- 
PDBu binding (Rozengurt, 1986; Zhang et al., 1990a; Spie- 
gel, 1989). In agreement with our previous studies, prolonged 
treatment with TPA abolished the mitogenic effect of TPA (in 
the absence or presence of insulin, Table 111). In contrast, the 
responses to other mitogens which do not require activation 
of PKC,  such  as insulin  and  sphingosine  (Hesketh et al., 
1988; Zhang et al., 1990a), were not affected. Downregula- 
tion of PKC did not eliminate the ability of SPC to stimulate 
DNA synthesis, however, the response to SPC was reduced 
by ~50%  (Table III). 
Effect of SPC on [Ca2+], 
Recently, sphingosine and SPP were shown to cause the re- 
lease of calcium in viable, quiescent cultures of Swiss 3T3 
fibroblasts  (Zhang  et  al.,  1991).  Furthermore,  SPC  and 
sphingosine have been reported to release 45Ca2÷ from per- 
meabilized smooth muscle cells (Ghosh et al., 1990). Using 
digital imaging fluorescence microscopy, we investigated the 
effect of SPC on [Ca2+]i in quiescent Swiss 3T3 fibroblasts. 
In individual cells, basal [Ca2+]~ varied between 30-120 nM 
(n =  30), consistent with the values reported by others (Spie- 
gel and Panagiotopoulos, 1988; Hesketh et al., 1988; Zhang 
et al.,  1991).  There were genuine variations in the level of 
[Ca2+]i from cell to cell, even among quiescent cells, which 
were  morphologically  indistinguishable.  Application  of 
mitogenic concentrations of SPC induced a wave of [Ca2+]i 
which usually spread to cover the entire cell (representative 
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Figure 4. Changes in [Ca2+]i after addition of SPC. Quiescent cul- 
tures of Swiss 3T3 cells were loaded with fura-2/AM,  washed, and 
incubated  at 37°C  in  Locke's buffer containing  Ca  2+  (A) or in 
CaE*-free buffer containing  2  mM EGTA (B).  At the  indicated 
times (arrow),  10 #M SPC was added.  [Ca2+]i was determined by 
fura-2  imaging as described  in Materials  and  Methods.  In each 
case,  [Ca2+]i of five responsive cells are shown. In C, the mean 
peak changes in [Ca  2 +]i were measured in the absence (-) or pres- 
ence (+) of 2 mM extracellular calcium. Basal values were deter- 
mined  10 s before the addition of 10 #M SPC. 
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fura-2  fluorescence  intensity  ra- 
tio  imaging  in  Swiss  3T3  cells 
stimulated  with  various  concen- 
trations  of  SPC  (340  nm  im- 
age/380  nm image).  [Ca2÷]i was 
visualized by dual fluorescent mi- 
croscopy  imaging  using  fura-2/ 
AM as described in Materials and 
Methods.  Color scale at bottom 
depicts pixel intensity  of [Ca÷2]i 
from 0  nM  (pink) to  800  nM 
(red). Cells were challenged re- 
peatedly  with the indicated con- 
centrations of SPC and each treat- 
ment  was followed by a  resting 
period of 10 min in Locke's buffer 
before  the  next  challenge.  This 
period  allowed [Ca÷2]i to return 
to basal levels. 
examples of cells responsive to 10 #M SPC are depicted in 
Fig.  4  A).  The  SPC-induced  change  in  [Ca2÷]i peaked 
within 30 s, and then gradually returned to resting levels over 
the following 2-3 min. Neither the rate of onset (Fig. 4 B) 
nor the magnitude (Fig. 4 C) of this response was altered in 
the  absence  of extracellular  calcium,  suggesting  that  the 
SPC-induced change in [Ca2÷]i was because of mobilization 
of calcium from intracellular pools. However, shorter time 
was required  for  [Ca2+]i  to return to baseline levels in the 
absence of extracellular calcium. Also, lowering the temper- 
ature from 37°C  to room temperature did not alter the ki- 
netic characteristics of the SPC-induced increase in [Ca2÷]i 
(data not shown). The response to SPC was heterogeneous. 
Cells  differed  significantly  in  their  ability  to  respond  to 
different concentrations of SPC and some of the cells were 
entirely unresponsive (Fig. 5). SPC induced a detectable cal- 
cium release at a concentration as low as 200 nM (Fig. 5). 
However, both the magnitude of  the response and the fraction 
of the  cells showing  a  response increased  with increasing 
concentrations  of  SPC  (Fig.  5).  Concentrations  of  SPC 
above 30 ttM were not tested since they were cytotoxic. 
Effect of SPC on Phosphoinositide Breakdown 
Swiss  3T3  cells  have  receptors  for  the  peptide  hormone 
bradykinin  (BK)  which  activate polyphosphoinositide  hy- 
drolysis leading to the formation of inositol phosphates and 
the  release of calcium from internal  stores  (Powis  et al., 
1990; van Corven et al.,  1989). In agreement with previous 
reports, BK (1  /zM)  induced a transient [Ca2+]i elevation in 
Swiss 3T3 fibroblasts. The kinetics of the increase were simi- 
lar to those evoked by SPC (10 #M); however, the peak val- 
ues of [Ca2+]i were higher (Mattie, M. E., G. Brooker, and 
S. Spiegel, unpublished observations). To investigate the pos- 
sibility that SPC might stimulate phosphoinositide hydroly- 
sis to generate inositol phosphates which subsequently stim- 
ulate increased  [Ca2+]i,  the effect of SPC on the generation 
of inositol phosphates was examined. In agreement with pre- 
vious studies (Powis et al.,  1990),  stimulation of quiescent 
Swiss 3T3 fibroblasts with BK (1 #M) for 5 min resulted in 
a 1.3-fold increase in the levels of inositol phosphates (Table 
IV). In contrast, an optimal mitogenic concentration of SPC 
(10 #M) did not stimulate the production of inositol phos- 
phates (Table IV). This concentration of SPC was more than 
50-fold greater than that required to elicit a significant cal- 
cium response (Fig. 5) and was capable of reinitiating DNA 
synthesis in quiescent cells as effectively as  10%  (vol/vol) 
FBS (Desai and Spiegel, 1991).  However, at higher concen- 
trations,  SPC increased the level of InsP3  which was mea- 
sured directly (data not shown). 
Effect of SPC on PA 
We have previously demonstrated that the mitogenic effects 
of sphingosine and SPP are accompanied by an increase in 
levels ofPA (Zhang et al., 1990b,  1991). Consistent with our 
previous study (Zhang et al., 1990b), a mitogenic concentra- 
tion of sphingosine or SPP caused a  significant increase in 
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Stimulant  None  SPC  BK 
[3H]Inositol phosphate accumulation  18,450 4- 80  17,890 4- 310  23,445  4- 90 
(dpm/well) 
cAMP Accumulation 
(pmol/well) 
(-) Isoproterenol  3.5  4- 0.1  3.9  4- 0.04  ND 
(+) Isoproterenol  11.1  4- 0.7  12.4  4-  1.1  ND 
Confluent and quiescent cultures of Swiss 3T3 cells were exposed to SPC (10/~M) or BK (1 /zM), or vehicle (None)  for 5 rain, and levels of inositol phosphates 
were determined as described in Materials and Methods. Data are expressed as the total radioactivity  incorporated  into inositol mono-, bis-, and trisphosphate. 
Levels of cAMP  were measured in duplicate cultures with (+) or without (-) 10/~M isoproterenol. The values are means + SD. In separate experiments, cAMP 
levels after treatment with cholera  holotoxin  (1 t~g/ml)  were 30.5 + 5.3 and 55.3 + 5.0 pmol/well in the absence  or presence  of 10 tzM isoproterenol, respectively. 
ND, not determined. 
[32p]PA  levels  in  Swiss  3T3  cells  prelabeled  to  isotopic 
equilibrium with 32p~ (Fig.  6).  However, unlike sphingosine 
or SPP, SPC did not induce a measurable change in the con- 
tent of radiolabeled  PA with incubations as short as 5  min 
or as long as 6  h  (Fig.  6). 
Effect of SPC on cAMP Levels 
Mitogens,  such  as  insulin  and  cholera  toxin,  have  been 
shown to  increase  intracellular  cAMP concentrations  and 
thereby affect cellular metabolism and growth (Rozengurt et 
al.,  1981). In sharp contrast, the mitogenic effects of PA and 
sphingosine  are associated  with decreases  in cAMP levels 
(Murayama and Ui,  1987; Zhang et al.,  1990b). cAMP lev- 
els in cells which were treated with mitogenic concentration 
of SPC were not significantly different from untreated cells 
(Table IV). In comparison, cAMP levels increased  18- and 
3-fold,  respectively,  after  treatment  with  cholera  toxin  or 
isoproterenol.  In  further  experiments,  the  incubation  me- 
Figure 6. Lack of effect of SPC on PA levels. Confluent and quies- 
cent cultures  of Swiss 3T3 cells were prelabeled  with 32pi for 24 h 
and stimulated  with SPC (20 #M) for the indicated  time periods. 
After extraction,  lipids  were separated by TLC and 32p-PA ana- 
lyzed as described in Materials and Methods. The results  are ex- 
pressed as percent of  total radioactivity in phospholipids.  The inset 
bar graph depicts  accumulation of 32p-PA in response to SPC (20 
#M) or SPP (5 #M) after 10 min (dark  fill), and in response to SPC 
(20 tiM)  or sphingosine  (SPH, 20 #M) after 240 min (light  fill). 
Extensive studies on sphingosine-  and SPP-induced  PA accumula- 
tion have been reported previously (Zhang et al.,  1990a,b,  1991; 
Desai et al.,  1992). 
dium was supplemented with isoproterenol to allow accurate 
estimation of the cAMP suppression in intact cells,  as was 
done  in  previous  studies  with  PA  and  sphingosine 
(Murayama and Ui,  1987; Zhang et al.,  1990b).  Unlike the 
effects of sphingosine  (Zhang et al.,  1990b),  SPC did not 
cause any detectable  decrease  in the cellular  cAMP levels 
(Table IV). 
Effect of SPC on Arachidonic Acid Levels 
In many cell types, increased generation of unesterified AA 
and  concomitant production of oxygenated metabolites  of 
AA (collectively termed eicosanoids) often accompany in- 
creases  in  [Ca:+]~ (Irvine,  1982).  In quiescent  3T3  fibro- 
blasts prelabeled  with  [3H]AA, SPC  induced a  concentra- 
tion-  and  time-dependent  release  of radioactivity  into the 
medium (Fig.  7) which was identified as free AA. Loss of 
radiolabel from phospholipids completely accounted for the 
release of radioactivity from cells treated with SPC.  There 
was a small but significant decrease of [3H]AA-labeled PC, 
PE, and PI. In contrast, no significant loss of label from PS 
was observed. 
In contrast to SPC,  sphingosine had no significant effect 
on the  release  of AA (Fig.  7  B).  However,  it inhibits  the 
SPC-induced AA release (Fig. 7 B).  Similarly, sphingosine 
reduced SPC-induced mitogenesis  (Fig.  8).  Whereas  indi- 
vidually  either  sphingosine  or  SPC  stimulated  [3H]thymi- 
dine  incorporation  in  the  presence  or  absence  of insulin 
(Figs.  1 and 8; Tables I and III), when sphingosine and SPC 
were added simultaneously,  the response to SPC was sub- 
stantially  reduced (Fig.  8). 
Relationship between Arachidonic Acid, Calcium, 
and Mitogenesis in Response to SPC 
It was possible that the increase in AA induced by SPC was 
a  consequence  of  the  increase  in  [Ca2+]i. Thapsigargin 
(TG),  an irreversible  inhibitor of the ER Ca2+-ATPase that 
does not inhibit the plasmalemmal enzyme, is a useful agent 
to  deplete  intracellular  calcium  pools  (Thastrup  et  al., 
1990). TG stimulates a transient increase in intracellular cal- 
cium in 3T3  cells,  but does  not stimulate  a  significant in- 
crease  in  release  of AA in cells  prelabeled  with  pH]AA. 
Furthermore, treatment with TG for 25 min before the addi- 
tion of SPC completely blocks the ability of SPC (20 #M) 
to stimulate  an increase  in  [CaZ+]i, but only decreased the 
SPC-stimulated release of AA from phospholipids by 20%. 
These  results  indicate  that the  rise  in calcium induced by 
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Figure 7. Effect of SPC on AA release in intact Swiss 3T3 fibro- 
blasts. Confluent and quiescent cultures of Swiss 3T3 cells were 
prelabeled with [aH]arachidonic acid for 24 h and stimulated for 
10 min with various concentrations of SPC (A). Radioactivity re- 
leased from the cells (in medium devoid of BSA) was measured as 
described in Materials and Methods. Values represent means  + 
standard errors for triplicate determinations. In B, Swiss 3T3 cells 
prelabeled with [3H]arachidonie  acid were stimulated (in medium 
containing 20 #g/ml BSA) with vehicle (tilled circles), 20 #M SPC 
(filled squares),  20 #M sphingosine (open circles),  or SPC plus 
sphingosine (20 #M each, open squares). 
B 
SPC is probably not involved in the release of AA. A recent 
study has demonstrated that AA can stimulate elevation of 
[Ca2+]i in Jurkat T  lymphocytes (Chow and Jondal,  1990). 
Thus, it was of interest to examine whether AA can release 
calcium from internal sources in Swiss 3T3 fibroblasts. High 
concentrations of exogenous AA (33-66 #M) were found to 
transiently increase intraceUular calcium similar to SPC. 
Since the prominent signal transduction pathways that are 
affected by SPC are calcium mobilization and arachidonate 
release, we examined the direct effects of calcium mobiliza- 
tion (activated by ionomycin or TG) and exogenous AA on 
mitogenesis. In 3T3 fibroblasts, in agreement with other cell 
types (Ghosh et al.,  1991),  TG inhibits  [3H]thymidine in- 
corporation.  Similarly,  ionomycin  (1  #M)  which  signifi- 
cantly stimulates an increase in intracellular calcium, also 
decreases  [3H]thymidine incorporation and was cytotoxic. 
Figure 8. Effect of SPC, sphingosine, or both on DNA synthesis. 
[3H]Thymidine  incorporation was assayed as described in Materi- 
als and Methods after stimulation with vehicle (cont), 20 #M sphin- 
gosine (SPH), 20 #M SPC, or SPC plus sphingosine (20 pM each) 
in the  absence (dark fill)  or presence (light fill)  of 4  pg/ml of 
insulin. 
Lower concentrations of ionomycin (50-100 nM) were only 
weakly mitogenic. In agreement with other studies (Millar 
and Rozengurt, 1990; Gil et al., 1991; Takuwa et al., 1991), 
AA alone was not mitogenic and only slightly enhanced the 
mitogenic effect of insulin. Even a combination of AA, insu- 
lin, and a low concentration of ionomycin was much less po- 
tent than SPC.  Thus, none of the combinations of AA and 
agents which mobilize calcium gave a mitogenic effect that 
approached that of SPC. 
Discussion 
SPC Signaling Pathways 
Increased levels of SPC have been found in patients with 
Niemann-Pick disease  (Strasberg  and  CaUahan,  1987),  a 
form of sphingolipidosis resulting from a deficiency  of sphin- 
gomyelinase activity (Strasberg and Callahan,  1988).  The 
potential role of SPC in the pathophysiology of this disease 
was  suggested by its  deleterious effects on mitochondrial 
function  and  calcium  uptake  (Strasberg  and  Callahan, 
1988). At high concentrations, SPC has also been shown to 
induce neurite outgrowth in mouse neuroblastoma cell lines 
(Sugiyama et al.,  1990). More recently, we observed that at 
low  concentrations,  SPC  was  an  extremely potent  wide- 
spectrum growth promoting agent for a variety of cell types 
(Desai and Spiegel, 1991). SPC alone was much more mito- 
genic for Swiss 3T3 fibroblasts than other known growth fac- 
tors, such as insulin and EGE and it was as effective as FBS 
(Desai and Spiegel, 1991). SPC was also significantly more 
potent  than  structurally  related  sphingolipids,  including 
sphingosine and SPP. 
The effect of SPC appeared to be specific, since none of 
the other lysophospholipids tested were as potent as SPC. 
Surprisingly, lysophosphatidate was not mitogenic for Swiss 
3T3 fibroblasts,  in contrast to its potent mitogenic effects 
reported for quiescent Rat-1 fibroblasts and for diploid hu- 
man foreskin fibroblasts (van Corven et al.,  1989). Of the 
analogs tested, only lysophosphatidylcholine, platelet-acti- 
vating  factor,  and  lysoplatelet-activating factor had  mito- 
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this regard, a recent study demonstrated that lysophospha- 
tidylcholine potentiated the mitogenic effect of IL2 on T cell 
proliferation (Asaoka et al.,  1991) and EGF-dependent re- 
ceptor autophosphorylation in A431  cells (Igarashi et al., 
1990).  Furthermore, lysophosphatidylcholine has been im- 
plicated as a putative intracellular messenger (Rustenbeck 
and Lenzen, 1989; Asaoka et al., 1992). All of  the individual 
structural components of SPC appear essential for its strong 
mitogenic effect, since either acylation of the amino group 
with a fatty acid or acetyl group (Sugiyama et al., 1990), or 
absence of choline and phosphocholine groups  (SPP  and 
sphingosine, respectively) reduces its effects (Zhang et al., 
1990a;  1991). 
Involvement of PKC 
Sphingosine and other lysosphingolipids have been reported 
to inhibit PKC activity, modulating the cellular responses de- 
pendent on this enzyme (Hannun and Bell,  198% 1989). 
However, in contrast to a previous report that SPC inhibits 
PDBu binding to PKC (Hannun and Bell,  1987),  we ob- 
served that SPC did not compete with phorbol ester for bind- 
ing to PKC in intact Swiss 3T3 fibroblasts.  SPC also acted 
synergistically with TPA to stimulate mitogenesis of Swiss 
3T3 fibroblasts, suggesting that SPC does not act through in- 
hibition of PKC. These results, together with the ability of 
SPC to stimulate mitogenesis in 3T3 cells depleted of PKC 
activity, indicate that PKC cannot be the sole target for SPC- 
induced mitogenesis. However, we cannot exclude the possi- 
bility that PKC plays some role in the mitogenic effect of SPC 
since there was a  significant decrease in the SPC-induced 
stimulation of DNA synthesis after downregulation of PKC. 
Furthermore, the synergistic effects between SPC and TPA 
were not as pronounced as the synergistic effects between 
SPC and either insulin or EGE mitogens which are known 
to act independently of PKC (Hesketh et al.,  1988).  Thus, 
SPC may act through both PKC-dependent and -independent 
signaling pathways. In sharp contrast, we previously demon- 
strated the mitogenic activities of sphingosine (Zhang et al., 
1990a) and SPP (Zhang et al., 1991) in Swiss 3T3 cells were 
clearly independent of PKC. 
The Mitogenic Effect of SPC Correlates with [CaZ+]~ 
Using a digital imaging system for measurement of cytosolic 
free calcium, we observed that SPC induced transient, pan- 
cellular increases in [Ca2+]~. The rapid rise in [Ca2+]i was 
independent  of the  presence  of calcium  in  the  external 
medium,  indicating that the response was mainly due to 
mobilization of calcium from internal stores. Thus, SPC is 
also a calcium-mobilizing agonist in viable 3T3 fibroblasts, 
acting in a similar manner as sphingosine and SPP (Zhang 
et  al.,  1991). These  findings are  consistent  with  recent 
studies in which sphingosine or SPC were found to stimulate 
45Ca fluxes in permeabilized smooth muscle cells (Ghosh et 
al.,  1990).  Similar to SPP, and in contrast to sphingosine, 
the  effect of SPC  on  [Ca2+]i was  not notably altered by 
lowering the temperature.  Although mitogenic concentra- 
tions of SPC stimulated a rise in [Ca2+]~ in Swiss 3T3 cells, 
there was no detectable effect on accumulation of inositol 
phosphates; therefore, hasP3 probably does not mediate the 
SPC*stimulated cellular proliferation and may not be  in- 
volved in mobilization of intracellular calcium induced by 
SPC. Previously, we found that sphingosine stimulated for- 
mation of inositol phosphates (Zhang et al.,  1990b).  These 
data also suggest that SPC and sphingosine may act through 
different mechanisms. 
The mitogenic action of sphingosine was coupled to an in- 
crease in the levels of PA (Zhang et al., 1990b). Recently we 
have shown that SPP can also stimulate PA accumulation, 
likely through activation of phospholipase D (Desai et al., 
1992).  PA has been shown to act as an intracellular mes- 
senger that can regulate the activity of  ras-GAp, a component 
essential for cellular proliferation (Yu et al.,  1988;  Exton, 
1990;  Bocckino et al.,  1991). Furthermore, a recent study 
had demonstrated that there is a  PA-sensitive  intraceUular 
calcium pool  in  Jurkat  T  cells  which  is  independent of 
InsP3 levels (Breittmayer et al.,  1991). In sharp contrast to 
sphingosine or SPP, SPC did not cause a significant increase 
in PA levels in Swiss 3T3 fibroblasts. Therefore, whereas PA 
may mediate the mitogenic effects of sphingosine and SPP, 
PA is probably not involved in the mechanism of action of 
SPC. One obvious explanation for this is that the pathways 
mediating the mitogenic effect of SPC are not identical to 
those mediating the effects of sphingosine or SPE Alterna- 
tively, changes in PA production may be unrelated to mito- 
genesis and pathways essential for the mitogenicity of SPC, 
sphingosine, and SPP have not yet been completely charac- 
terized. 
The classical intracellular messenger, cAMP,  is also not 
likely involved in the SPC-induced stimulation of mitogene- 
sis or calcium mobilization, since SPC had no effects on the 
levels of cAME Sphingosine (Zhang et al., 1990b),  and SPP 
(Mattie, M. E., G. Brooker, and S. Spiegel, unpublished ob- 
servations) on the other hand, caused a drastic decrease in 
cellular cAMP levels,  representing another point of diver- 
gence between the effects of SPC and sphingosine or SPE 
Does Arachidonic Acid Mediate 
SPC-induced Mitogenesis ? 
AA has been implicated in the regulation of mitogenesis in 
3T3 fibroblasts (Millar and Rozengurt, 1990; Takuwa et al., 
1991). The mitogenic peptides bombesin and mastoparan in- 
duce mobilization of unesterified AA in Swiss 3T3  fibro- 
blasts (Millar and Rozengurt, 1990; Takuwa et al., 1991; Gil 
et al.,  1991). Furthermore, exogenous AA was shown to 
potentiate the mitogenic effect of insulin on Swiss 3T3 cells 
(Takuwa et al.,  1991). 
Mitogenic concentrations of SPC  stimulated release of 
3H-labeled AA which seemed not to be secondary to the in- 
crease in [Ca2+]i, since 1"(; blocked the increase in calcium 
without significant effect on AA release. On the other hand, 
AA could contribute to the increase in intracellular calcium. 
However, this also seems unlikely since the effect on calcium 
is more rapid than the release of AA induced by SPC, and 
exogenous AA was only weakly mitogenic and required very 
high concentrations to stimulate an increase in intracellular 
calcium. The increased AA by itself is not likely the sole 
mediator of both the SPC-induced increase in intracellular 
calcium and the SPC-induced mitogenesis. 
Although the significance of the AA released during the 
mitogenic response to SPC is not clear, it is intriguing to 
note that PKCot is the predominant PKC isoform in Swiss 
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1989).  This isoenzyme can be activated by free AA in the 
presence  of calcium  (Nishizuka,  1992).  The  increase  in 
[Ca2+]i induced by SPC, together with the increase in AA 
levels, might activate PKCct and could account for the par- 
tial PKC dependency observed in these studies. The inhibi- 
tion by sphingosine of both SPC-induced AA release and 
SPC-stimulated mitogenesis provides the most compelling 
evidence that AA may play a role in mediating SPC mitoge- 
nicity.  These  results  also  strengthen our  conclusion that 
sphingosine and SPC do not use identical pathways for the 
stimulation of cell division. 
Is Endogenous SPC a Regulator of  Mitogenesis? 
Since SPC  is more potent than sphingosine,  SPP,  sphin- 
gomyelin, and ceramide in stimulating DNA synthesis, it 
seems most likely that SPC itself is the active agent. Exoge- 
nous SPC is readily taken up by cells and metabolized rela- 
tively slowly after uptake, primarily to phosphocholine and 
sphingosine.  Based  on  the  time  course  of  sphingosine 
production from SPC and the magnitude of the increase, it 
seems  likely  that  sphingosine  cannot  mediate  the  SPC- 
induced increase in intracellular calcium and is probably not 
involved in the mitogenic effect of SPC.  Furthermore, the 
signal  transduction pathway mediated by  SPC  is  distinct 
from that used by sphingosine or SPP. Therefore, the SPC 
itself  probably acts as the mediator of  mitogenic stimulation. 
In  this  regard,  it is  interesting to  note that a  significant 
amount of SPC was incorporated into Swiss 3T3 cells within 
a very short time which is consistent with our observation 
that  SPC  is  a  very  potent  mitogen  even  after  a  brief 
treatment. 
Although SPC has not yet been detected in normal cells, 
it has been found in the spleens of patients with Niemann- 
Pick disease (Strasberg and Callahan, 1987).  Earlier, SPC 
had been proposed to be  a  potential precursor of sphin- 
gomyelin.  Brady  et  al.  first  reported  the  formation  of 
[t4C]sphingomyelin  after incubation of SPC  and stearoyl- 
[t4C]CoA with rat brain homogenates (Brady et al.,  1965). 
SPC was recently reported to stimulate an increase in sphin- 
gomyelin levels in neuroblastoma cells  (Sugiyama et al., 
1990) and in human leukemia HL-60 cells (Dressier et al., 
1991). In both of  these studies, the increase in levels of sphin- 
gomyelin was associated with differentiation. Nevertheless, 
exogenous SPC in 3T3 cells was not significantly converted 
to sphingomyelin. 
The formation of SPC from sphingosine and CDP-choline, 
originally reported by Fujino et al., suggested that cells may 
have the capacity to synthesize SPC (Fujino and Negishi, 
1968; Fujino et al., 1968). In contrast, Stoffel and Melzner 
were unable to detect SPC synthesis using rat liver micro- 
somes, a preparation which is rich in CDP-choline/ceramide 
choline phosphotransferase activity (Stoffel and Melzner, 
1980).  Similarly,  phosphatidylcholine/ceramide  choline- 
phosphotransferase activity in plasma membrane fractions 
from mouse Ehrlich ascite cells, which normally catalyzes 
formation of sphingomyelin by the transfer of phosphocho- 
line from phosphatidylcholine to ceramide, did not catalyze 
phosphocholine transfer using sphingosine as an acceptor to 
form SPC (Marggraf and Kanfer, 1984).  Furthermore, re- 
cent studies from Pagano's laboratory clearly demonstrated 
that most, if not all, sphingomyelin is synthesized in mam- 
malian cells by transfer of phosphorylcholine from phos- 
phatidylcholine to ceramide,  thus suggesting that SPC  is 
probably not a precursor of sphingomyelin (Pagano,  1988; 
Futerman et al.,  1990).  However,  in analogy to receptor- 
linked phospholipase A2 which catalyzes liberation of AA 
from phospholipids,  a  receptor-linked "sphingomyelin de- 
acylase" might function to  increase endogenous levels  of 
SPC, which potentially could act as a modulator of cellular 
proliferation via distinct signaling pathways. 
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